Lee Kalowski

Insider Reports History

Entity
Individual
Location
C/O Tokai Pharmaceuticals, Inc., One Broadway, 14 Th Floor, Cambridge, MA
Signature
/s/ Eric Bell, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Lee Kalowski:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Homology Medicines, Inc. CFO and President Stock Option (Right to Buy) 161K $2.16M $13.42 Mar 25, 2024 Direct
BICYCLE THERAPEUTICS plc President and CFO Ordinary Shares 30.3K $530K $17.50 Apr 3, 2023 Direct

Insider Reports Filed by Lee Kalowski

Symbol Company Period Transactions Value $ Form Type Date Filed Role
QTTB Homology Medicines, Inc. Mar 25, 2024 1 $0 4 Mar 27, 2024 CFO and President
QTTB Homology Medicines, Inc. Mar 25, 2024 0 $0 3 Mar 27, 2024 CFO and President
BCYC BICYCLE THERAPEUTICS plc Apr 3, 2023 1 -$7.94K 4 Apr 5, 2023 President and CFO
BCYC BICYCLE THERAPEUTICS plc Jan 3, 2023 3 -$52.7K 4 Jan 5, 2023 President and CFO
BCYC BICYCLE THERAPEUTICS plc Jan 3, 2022 2 $0 4 Jan 5, 2022 President and CFO
BCYC BICYCLE THERAPEUTICS plc Sep 2, 2021 3 -$302K 4 Sep 3, 2021 President and CFO
BCYC BICYCLE THERAPEUTICS plc Aug 26, 2021 6 -$224K 4 Aug 27, 2021 President and CFO
BCYC BICYCLE THERAPEUTICS plc Aug 23, 2021 3 -$236K 4 Aug 25, 2021 President and CFO
BCYC BICYCLE THERAPEUTICS plc Jul 29, 2021 5 -$373K 4 Jul 30, 2021 President and CFO